Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
Breast cancer is the most common malignancy among women worldwide, excluding non-melanoma skin cancer. It is now well understood that breast cancer is a heterogeneous entity that exhibits distinctive histological and biological features, treatment responses and prognostic patterns. Therefore, the id...
Main Authors: | Cuicui Lu, Duncan Wei, Yahui Zhang, Peng Wang, Wen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.710538/full |
Similar Items
-
Expression of Four Long Non-coding RNAs in Breast Cancer and Their Relation with Patient's Prognosis
by: SU Jiaqing, et al.
Published: (2020-02-01) -
Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets
by: Marek Vecera, et al.
Published: (2018-09-01) -
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
by: Xiao-hong Mao, et al.
Published: (2021-01-01) -
Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers
by: Dominik A. Barth, et al.
Published: (2020-09-01) -
Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
by: Yachen Shi, et al.
Published: (2021-09-01)